Vitae Pharmace Cm ST (VTAE)
21.00 +0.01 (+0.05%) 10/24/16 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
for Mon, Oct 24th, 2016
Results
download Want to compare other data? Select Fields| Symbol | VTAE | XERS | KALV | ||
| Company | Vitae Pharmace Cm ST | Xeris Pharmaceuticals Inc | Kalvista Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 20.99 | 4.08 | 11.73 | ||
| High | 21.00 | 4.20 | 12.17 | ||
| Low | 20.99 | 4.04 | 11.73 | ||
| Last | 21.00 | 4.11 | 12.00 | ||
| Change | +0.01 | +0.03 | +0.26 | ||
| % Change | +0.05% | +0.74% | +2.17% | ||
| Volume | 541,100 | 1,906,600 | 495,500 | ||
| 20-Day Average Volume | 469,775 | 3,780,485 | 729,025 | ||
| Previous Close | 20.99 | 4.08 | 11.74 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 20.97 | 4.86 | 11.56 | ||
| 20-Day Raw Stochastic | 76.92% | 13.47% | 82.69% | ||
| 20-Day Relative Strength | 83.12% | 44.01% | 55.08% | ||
| Weighted Alpha | +5.70 | +117.72 | +9.00 | ||
| Today's Opinion | N/A | 56% Buy | 72% Buy | ||
| Previous Opinion | N/A | 56% Buy | 72% Buy | ||
| Last Month's Opinion | N/A | 100% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.05% since 10/17/16 | +4.05% since 04/10/25 | +13.85% since 04/10/25 | ||
| Low | 20.96 on 10/18/16 | 3.84 on 04/11/25 | 10.41 on 04/11/25 | ||
| High | 21.00 on 10/24/16 | 4.39 on 04/15/25 | 12.35 on 04/15/25 | ||
| 1-Month | |||||
| %Chg | +0.29% since 09/23/16 | -18.29% since 03/17/25 | -3.92% since 03/17/25 | ||
| Low | 20.90 on 09/27/16 | 3.81 on 04/10/25 | 9.23 on 04/09/25 | ||
| High | 21.03 on 10/03/16 | 6.07 on 03/26/25 | 12.58 on 03/25/25 | ||
| 3-Month | |||||
| %Chg | +95.17% since 07/22/16 | +28.44% since 01/17/25 | +44.58% since 01/17/25 | ||
| Low | 6.75 on 08/31/16 | 3.21 on 01/21/25 | 8.25 on 01/21/25 | ||
| High | 21.03 on 10/03/16 | 6.07 on 03/26/25 | 12.90 on 03/12/25 | ||
| 6-Month | |||||
| %Chg | +159.90% since 04/22/16 | +35.20% since 10/17/24 | -0.74% since 10/17/24 | ||
| Low | 6.01 on 05/05/16 | 2.82 on 11/18/24 | 7.30 on 01/13/25 | ||
| High | 21.03 on 10/03/16 | 6.07 on 03/26/25 | 12.90 on 03/12/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 605,390 | 632,693 | 596,592 | ||
| Shares Outstanding, K | 28,840 | 153,940 | 49,716 | ||
| Annual Sales | 580,000 | 203,070,000 | 0 | ||
| Annual Net Income | -43,980,000 | -54,840,000 | -126,640,000 | ||
| Last Quarter Sales | 0 | 60,100,000 | 0 | ||
| Last Quarter Net Income | -10,410,000 | -5,110,000 | -48,510,000 | ||
| 60-Month Beta | 0.51 | 1.37 | 0.39 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.36 on 08/03/16 | -0.03 on 03/06/25 | -0.92 on 03/12/25 | ||
| Latest Earnings Date | 11/03/16 | 05/08/25 | 03/10/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||